CHC Healthcare Group · TWSE:4164
CHC Healthcare — Investor Conference (November 2019)
36 slides from CHC Healthcare's conference presentation, Nov 29, 2019
Slide 1: Investor Conference
Investor Conference 4164 TT Nov 29, 2019
Slide 2: Dual ISO Certifications
Dual ISO Certifications ISO 9001 Quality Management Systems OHSAS 18001 Occupational Health and Safety Management Certification 2
Slide 3: Disclaimer
Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Healthcare Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prepa
Slide 4: Company Introduction
Company Smart Health Introduction Health Care 4
Slide 5: Company Introduction
Company Smart Health Introduction Health Care 5
Slide 6: Company Introduction
Company Introduction • Name： CHC Healthcare Group (4164 TT) • Date of establishment： 2009/11/27 (First subsidiary, Chiu Ho Instruments & Reagent, was founded in 1977) • President： Mr. Pei-Lin, Lee • Headquarters： Taipei • Branches： Taichung, Kaohsiung, Beijing, Guangzhou & Jakarta • Major business：
Slide 7: Business Model
Business Model Manufacturer Medical Direct Selling CHC Management Service Hospital & Clinic 7
Slide 8: Annually Operating Revenue - 2015~2019
Annually Operating Revenue - 2015~2019 (NT$ thousand) 3,000,000 2,395,331 2,507,466 2,493,639 2,500,000 2,205,206 2,117,116 2,000,000 1,500,000 1,000,000 500,000 - 2015 2016 2017 2018 2019 Jan to Oct 8
Slide 9: Profitability - 2015~2019
Profitability - 2015~2019 (NT$ thousand) (NT$) 400,000 4 317,829 313,759 3.5 300,000 3 222,687 2.32 2.5 2.28 200,000 2 1.73 160,604 1.5 100,000 1.14 1 0.5 -89,286 0 0 -0.62 -0.5 -100,000 -1 2015 2016 2017 2018 2019 Q1-Q3 Profit for the period Basic EPS 9
Slide 10: Earnings Distribution & Dividend Yield - 2014~2018
Earnings Distribution & Dividend Yield - 2014~2018 (NT$) 2.5 10% 9% Cash Average 2 8% dividends Dividend closing price per share yield 7% for the year (NT$) 1.5 6% 2014 2 72.86 3% 5% Cash dividends per share 2015 2.004 56.22 4% Dividend yield 1 4% 2016 1.004 49.68 2% 3% 2017 1.1 40.69 3% 0.5 2% 2018
Slide 11: Company Introduction
Company Smart Health Introduction Health Care 11
Slide 12: Elekta Linear Accelerator Versa HD
Elekta Linear Accelerator Versa HD™ Versatile, all-in-one radiotherapy system Versa HD™ – Precise ･Intelligent ･ Quality Assured 12
Slide 13: Elekta Linear Accelerator
Elekta Linear Accelerator 13
Slide 14: Elekta MR-Linac
Elekta MR-Linac Unity – Two worlds, one future 14
Slide 15: Elekta MR-Linac
——St—“‘CSé™;*# Elekta MR-Linac @Elekta Crystal clear = a i ae REE CHC HEALTHCARE GROUP 15
Slide 16: Elekta MR-Linac
Elekta MR-Linac “We needed online, real-time, diagnostic quality MR imaging within the treatment workflow. Elekta Unity is the only system that can provide this.” Professor Dr Daniel Zips, Medical Director, CCC Tübingen-Stuttgart, Germany 16
Slide 17: IBA Proton Therapy
IBA Proton Therapy 30+ 50+ 65%+ YEARS OF EXPERIENCE CENTERS IN OPERATION / DEVELOPMENT PATIENTS TREATED WITH IBA 17
Slide 18: IBA Proton Therapy
IBA Proton Therapy ( ba 120 + 1 Pee Y Electrons (21 MeV) | Carbon (270 MeV/u) | A Photons 8 8 ro) 8 ts GY) *#22 CHC HEALTHCARE GROUP
Slide 19: IBA Proton Therapy
——=——“‘SC™; e IBA Proton Therapy ( ba PROTEUS®ONE THINK BIG, SCALE SMART SMART SETUP SMART IMAGING SMART WORKFLOW GY *#4%22 lS cH HEALTHCARE GROUP
Slide 20: IBA Proton Therapy
IBA Proton Therapy < Pencil Beam Scanning by IBA > 20
Slide 21: IBA Proton Therapy
IBA Proton Therapy Think Big, Scale Smart S2C2: next generation cyclotron design Only compact solution with IMPT Equip with Pencil Beam Scanning Efficient workflow and operations 21 ProteusONE
Slide 22: IMRIS Hybrid Surgical Theatre
IMRIS Hybrid Surgical Theatre 22
Slide 23: IMRIS Hybrid Surgical Theatre
IMRIS Hybrid Surgical Theatre 23
Slide 24: Hill-Rom Robotic OR
Hill-Rom Robotic OR Redefining Patient Positioning in da Vinci® Surgery 24
Slide 25: Hill-Rom Robotic OR
Hill-Rom Robotic OR Wireless Connectivity Robust connection to the da Vinci® Xi™ and long battery life to reduce clutter in the OR Trumpf Medical dV Remote Control Easy-to-use remote guides OR team through setup and intraoperative use, providing precise table angles to the entire OR team. Range of M
Slide 26: Company Introduction
Company Smart Health Introduction Health Care 26
Slide 27: World Aging Trend
World Aging Trend Year when ageing status changed Speed of population ageing (Year) Ageing Society Aged Society Super-Aged society 7% to 14% 14% to 20% (7%) (14%) (20%) Taiwan 1993 2018 2026(e) 25 8(e) Japan 1970 1994 2005 24 11 South Korea 1999 2017 2026(e) 18 9(e) Singapore 1999 2019(e) 2026(e) 20
Slide 28: Cyberdyne HAL
Cyberdyne HAL® Wy LCYBLERIOYNE TN AELR Ceveerovne 7k He +E BS (RE LA ARC YBERDYNERRA SH HALRHAW ANAL 28
Slide 29: Cyberdyne HAL
29 (oO Cyberdyne HAL® Wy LCYBLERIOYNE Pee,
Slide 30: Cyberdyne HAL
Cyberdyne HAL® 30
Slide 31: Cyberdyne HAL
——t—“‘=OS Cyberdyne HAL® O71 THINK First of all, think “I want to walk!” O2seEnD ving the signals, muscles move. HAL? reads signals. © CYBLGEROYNE O4move HAL® moves as the wearer OS reeoaack The brain learns m GY A282 (CHC HEALTHCARE GROUP
Slide 32: Cyberdyne HAL
Cyberdyne HAL® *Source: Great Big Story, Youtube 32
Slide 33: Market Information of Elderly Care Industry
Market Information of Elderly Care Industry • Market Gap in Taiwan The Dependent Elderly Market Gap Capacity Demand Amount % Institution for 105,066 421,800 316,734 75% physical incapacity Institution for 1,291 155,100 153,809 99% mental incapacity The Independent Elderly Market Gap Capacity Demand
Slide 34: Partnership with Sakurajyuji Group
Partnership with Sakurajyuji Group 34
Slide 35: Enter Elderly Care Market with New Perspective
Enter Elderly Care Market with New Perspective • Aging in Place • Preventive Medicine • Continuing Care 35
Slide 36: Thank you
Thank you 36
CHC Healthcare Group — Investor Conference (November 2019) on 6ix